admin

Antazoline Sulfate Market Poised for Growth Amid Rising Ocular Allergy Cases

Developments in formulations and growing demand for effective antihistamines drive market expansion. Industry Overview Antazoline sulfate market is set to expand steadily between 2025 and 2035, with a forecasted CAGR of around 2.6%. Growth is mainly driven by the rising incidence of allergic diseases such as conjunctivitis and rhinitis that require effective treatment using antihistamines. […]

Antazoline Sulfate Market Poised for Growth Amid Rising Ocular Allergy Cases Read More »

Senores Pharmaceuticals Started Operating at the Greenfield API Plant in Gujarat

Senores Pharmaceuticals Ltd. has inaugurated its newly established Greenfield Active Pharmaceutical Ingredient (API) plant on 26 February 2025 at Mehsana, Gujarat, India, and started production activities too. This strategic expansion marks a milestone in the company’s growth, while improving its capabilities in the pharmaceutical manufacturing sector. About Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd. is an

Senores Pharmaceuticals Started Operating at the Greenfield API Plant in Gujarat Read More »

Africa’s Push for API Self-Reliance: From Importer to Innovator

Africa mainly needs to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) to remove the dependency on imports, improve healthcare outcomes, and drive economic growth. Advancements in technologies and international collaborations can transform API manufacturing, boost African pharmaceutical development, and make Africa self-reliant. Africa’s pharmaceutical industry is at a crucial crossroads, with major developments

Africa’s Push for API Self-Reliance: From Importer to Innovator Read More »

Trump’s Pharmaceutical Tariff Threats API Industry and Global Concerns over Drug Supply Chains​

Former US President Donald Trump has revived global trade tensions by declaring plans to impose significant tariffs on imported pharmaceuticals and active pharmaceutical ingredients (APIs). This move is intended to bolster domestic manufacturing, however, has raised alarms about potential disruptions in the global drug supply chain and increased medication costs for consumers.   This move

Trump’s Pharmaceutical Tariff Threats API Industry and Global Concerns over Drug Supply Chains​ Read More »